Immunological effects of the TGFß-blocking antibody GC1008 in malignant pleural mesothelioma patients.

Stevenson, James P; Kindler, Hedy L; Papasavvas, Emmanouil; Sun, Jing; Jacobs-Small, Mona; Hull, Jennifer; Schwed, Daniel; Ranganathan, Anjana; Newick, Kheng; Heitjan, Daniel F; Langer, Corey J; McPherson, John M; Montaner, Luis J; Albelda, Steven M

Stevenson, James P; Kindler, Hedy L; Papasavvas, Emmanouil; Sun, Jing; Jacobs-Small, Mona; Hull, Jennifer; Schwed, Daniel; Ranganathan, Anjana; Newick, Kheng; Heitjan, Daniel F; Langer, Corey J; McPherson, John M; Montaner, Luis J; Albelda, Steven M.

Afiliação

Stevenson JP; Penn Mesothelioma and Pleural Program; Perelman School of Medicine of the University of Pennsylvania; Philadelphia, PA USA.

Oncoimmunology ; 2(8): e26218, 2013 Aug 01.

Article em En | MEDLINE | ID: mdl-24179709

Palavras-chave

GC1008; anti-TGFß antibody; antibody therapy; clinical trial; immunotherapy; malignant mesothelioma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2013 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2013 Tipo de documento: Article